WV HB3070

Defines "nonopioid medicinal drug or drug product" as FDA-approved medications that reduce pain without acting on opioid receptors

Prohibits insurance providers, Medicaid, pharmacy benefit managers, and PEIA from disadvantaging nonopioid pain medications compared to opioids through more restrictive coverage criteria, stricter prior authorization requirements, or higher cost-sharing tiers

Requires the West Virginia Bureau of Public Health to develop and publish an educational pamphlet on nonopioid alternatives for pain treatment, following CDC prescribing guidelines

Directs healthcare practitioners to consider prescribing nonopioid medications as the first line of pain control when clinically appropriate

Requires practitioners to discuss nonopioid alternatives with patients before prescribing opioids, document that alternatives were considered, and refer patients to the Bureau of Public Health's educational materials (with exceptions for critical care, emergency, and hospice settings)